Zeptide Injection 2.5 mg/0.5 ml is a novel injectable antidiabetic medication containing Tirzepatide, an advanced dual-action glucose-lowering agent developed for the management of type 2 diabetes mellitus. Tirzepatide is a first-in-class molecule that acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, offering superior glycemic control along with significant metabolic benefits.

Type 2 diabetes is a chronic metabolic disorder characterized by insulin resistance and impaired insulin secretion. Zeptide Injection addresses both of these mechanisms by enhancing insulin secretion in a glucose-dependent manner, suppressing inappropriate glucagon release, slowing gastric emptying, and reducing appetite. These combined effects help achieve sustained blood glucose control while also supporting meaningful weight reduction, an important benefit for many patients with type 2 diabetes.

Zeptide Injection is administered once weekly via subcutaneous injection, making it a convenient and patient-friendly option for long-term diabetes management. The 2.5 mg dose is typically used as a starting dose to allow the body to adjust to therapy and minimize gastrointestinal side effects before dose escalation, as recommended by healthcare professionals.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features

Indications

Zeptide Injection is indicated for:

• Management of type 2 diabetes mellitus in adults

• Improvement of glycemic control as an adjunct to diet and exercise

• Support for weight reduction in overweight or obese patients with type 2 diabetes

• Combination therapy with other antidiabetic agents, including metformin, insulin, or oral hypoglycemics, as advised by a physician

Active Ingredient

• Tirzepatide 2.5 mg per 0.5 ml

Tirzepatide’s dual GIP and GLP-1 receptor activity provides enhanced metabolic effects compared to single incretin-based therapies.

Benefits

• Dual Mechanism of Action: Targets both GIP and GLP-1 receptors for improved glucose regulation.

• Effective Glycemic Control: Reduces fasting and postprandial blood glucose levels.

• Weight Management Support: Helps reduce appetite and caloric intake.

• Once-Weekly Dosing: Improves patient adherence and convenience.

• Glucose-Dependent Action: Lowers risk of hypoglycemia when used appropriately.

Dosage and Administration

• Route: Subcutaneous injection

• Frequency: Once weekly, on the same day each week

• Starting Dose: 2.5 mg once weekly for initial treatment

The injection may be administered in the abdomen, thigh, or upper arm. Dose escalation should only be done under medical supervision. Zeptide Injection should not be used for type 1 diabetes or diabetic ketoacidosis.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

Precautions

• Use under the supervision of a qualified healthcare professional.

• Caution is advised in patients with a history of pancreatitis or severe gastrointestinal disease.

• Not recommended for patients with known hypersensitivity to Tirzepatide or any excipients.

• Safety during pregnancy and breastfeeding should be assessed by a physician.

Side Effects

• Common side effects may include nausea, vomiting, diarrhea, decreased appetite, and abdominal discomfort.

• These effects are usually mild to moderate and tend to decrease with continued use.

Storage

• Store refrigerated at 2°C to 8°C.

• Do not freeze.

• Protect from light.

• Keep out of reach of children.

Why Choose Zeptide Injection?

• Advanced dual incretin therapy for comprehensive diabetes control

• Convenient once-weekly dosing schedule

• Supports both blood glucose control and weight management

• High-quality injectable formulation from SK Pharma.